A U.S. Post-Approval Study of the SYNERGY 4.50/5.0 mm Everolimus-Eluting Platinum Chromium Coronary Stent System EVOLVE 4.5/5.0
Clinical Trial Grant
Awarded By
Boston Scientific Corporation
Start Date
February 18, 2020
End Date
January 24, 2024
Awarded By
Boston Scientific Corporation
Start Date
February 18, 2020
End Date
January 24, 2024